Blair William & Co. IL trimmed its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 45.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,744 shares of the medical research company's stock after selling 3,062 shares during the period. Blair William & Co. IL's holdings in IQVIA were worth $947,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of IQV. AdvisorNet Financial Inc lifted its position in shares of IQVIA by 327.6% during the 4th quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company's stock worth $29,000 after buying an additional 95 shares during the last quarter. Rise Advisors LLC acquired a new stake in shares of IQVIA in the 1st quarter valued at approximately $31,000. Riverview Trust Co acquired a new position in IQVIA during the 1st quarter worth approximately $32,000. Activest Wealth Management bought a new position in IQVIA in the 4th quarter valued at approximately $35,000. Finally, Security National Bank acquired a new stake in IQVIA in the fourth quarter valued at approximately $41,000. 89.62% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. Morgan Stanley increased their price target on IQVIA from $270.00 to $280.00 and gave the company an "overweight" rating in a research note on Tuesday. Barclays increased their target price on IQVIA from $255.00 to $275.00 and gave the company an "overweight" rating in a research report on Tuesday. Truist Financial increased their target price on IQVIA from $292.00 to $300.00 and gave the company a "buy" rating in a research report on Tuesday. UBS Group raised their price objective on shares of IQVIA from $295.00 to $300.00 and gave the company a "buy" rating in a report on Tuesday. Finally, Evercore ISI lifted their target price on shares of IQVIA from $230.00 to $270.00 and gave the stock an "outperform" rating in a research report on Tuesday. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $265.00.
View Our Latest Analysis on IQVIA
IQVIA Trading Down 2.6 %
NYSE IQV traded down $6.43 during trading hours on Tuesday, hitting $238.80. 1,918,130 shares of the company's stock were exchanged, compared to its average volume of 1,082,404. The firm has a market cap of $43.51 billion, a price-to-earnings ratio of 32.81, a PEG ratio of 2.06 and a beta of 1.49. The stock has a 50-day simple moving average of $219.86 and a 200 day simple moving average of $229.08. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 2.02. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $261.73.
IQVIA (NYSE:IQV - Get Free Report) last announced its quarterly earnings data on Monday, July 22nd. The medical research company reported $2.64 EPS for the quarter, topping the consensus estimate of $2.57 by $0.07. The company had revenue of $3.81 billion during the quarter, compared to the consensus estimate of $3.79 billion. IQVIA had a net margin of 9.01% and a return on equity of 29.17%. The company's quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.22 EPS. On average, equities analysts forecast that IQVIA Holdings Inc. will post 10.11 EPS for the current fiscal year.
About IQVIA
(Free Report)
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Recommended Stories
- Five stocks we like better than IQVIA
- Stock Market Sectors: What Are They and How Many Are There?
- ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
- Options Trading - Understanding Strike Price
- Leading Beverage Company's Stock Bubbles Higher: Rally Ahead
- What is Forex and How Does it Work?
- Can This Meme Stock Stage One Last Rally?
→ This TSLA short trade is on a nine win hot streak (From WealthPress) (Ad)
Should you invest $1,000 in IQVIA right now?
Before you consider IQVIA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IQVIA wasn't on the list.
While IQVIA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
7 Stocks to Buy And Hold Forever
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
